Latest Insider Transactions at Invitae Corp (NVTA)
This section provides a real-time view of insider transactions for Invitae Corp (NVTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Invitae Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Invitae Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 24
2020
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,427
-0.81%
|
$118,923
$49.59 P/Share
|
|
Nov 20
2020
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
8,683
-0.45%
|
$408,101
$47.85 P/Share
|
|
Nov 20
2020
|
Sean E George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.77%
|
$40,000
$8.7 P/Share
|
|
Nov 18
2020
|
Shelly D Guyer Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.44%
|
$141,000
$47.09 P/Share
|
|
Nov 17
2020
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
5,000
-1.18%
|
$230,000
$46.17 P/Share
|
|
Nov 16
2020
|
Eric Aguiar Director |
SELL
Open market or private sale
|
Direct |
30,000
-88.14%
|
$1,380,000
$46.71 P/Share
|
|
Nov 16
2020
|
Eric Aguiar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+36.11%
|
$270,000
$9.61 P/Share
|
|
Nov 13
2020
|
Katherine Stueland Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.42%
|
$48,000
$48.0 P/Share
|
|
Oct 13
2020
|
Katherine Stueland Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.42%
|
$51,000
$51.36 P/Share
|
|
Oct 09
2020
|
Robert L Nussbaum Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,550
+2.95%
|
$58,950
$9.9 P/Share
|
|
Oct 05
2020
|
Robert F. Werner Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+33.21%
|
-
|
|
Oct 02
2020
|
Jason W. Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,039,227
+50.0%
|
-
|
|
Mar 28
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,111,111
+11.72%
|
$4,444,444
$4.5 P/Share
|
|
Jan 03
2017
|
Robert L Nussbaum Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,666
+50.0%
|
$1,666
$1.26 P/Share
|